newsfilter
← Latest News
GlobeNewswire·

Ascendis to Share Its Latest Endocrinology Rare Disease Data at ESPE 2026

COPENHAGEN, Denmark, Sept. 07, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (NASDAQ:ASND) today announced it will share the latest data from its Endocrinology Rare Disease programs during ESPE 2026, the annual